NOT:ETR
Novartis AG
€123.70
arrow_upward
+1.36%(+1.66) 1D
Sep 21, 5:35:42 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOT...
Open
€122.20
High
€123.86
Low
€122.20
Mkt. cap
287.11B
Avg. vol.
5.50K
Volume
6.43K
52-wk high
€144.12
52-wk low
€103.16
No. of employees
75K
Open
€122.20
High
€123.86
Low
€122.20
Mkt. cap
287.11B
Avg. vol.
5.50K
Volume
6.43K
52-wk high
€144.12
52-wk low
€103.16
No. of employees
75K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
AD HOC NEWS
·
7 hours ago
Novartis stock holds steady as investors weigh recent results and pipeline outlook
AD HOC NEWS
·
1 day ago
Novartis stock falls as clinical setbacks weigh despite Cosentyx EU boost
Yahoo Finance
·
2 days ago
Novartis (SWX:NOVN) Takes Full Control Of A Brain Delivery Platform
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com